Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents (Q51900054)

17 April 2018

title

Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents (English)

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

11 July 2024

0 references

1 reference

Tomohiro Abekawa

1

1 reference

17 April 2018

Koki Ito

2

1 reference

17 April 2018

Shin Nakagawa

3

1 reference

17 April 2018

Yasuya Nakato

4

1 reference

17 April 2018

Tsukasa Koyama

5

1 reference

17 April 2018

language of work or name

English

0 references

publication date

15 September 2010

1 reference

17 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S092099641001457X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

https://api.elsevier.com/content/article/PII:S092099641001457X?httpAccept=text/plain

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

11 July 2024

published in

Schizophrenia Research

1 reference

17 April 2018

volume

125

1 reference

17 April 2018

issue

1

1 reference

17 April 2018

page(s)

77-87

1 reference

17 April 2018

Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex

11 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

11 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus

11 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.

11 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

DNA fragmentation decreased in schizophrenia but not bipolar disorder

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona. The rapporteurs' report

11 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia

11 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Exercise activates the phosphatidylinositol 3-kinase pathway

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia

11 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

11 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Apoptotic mechanisms and the synaptic pathology of schizophrenia

11 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

To die or not to die: an overview of apoptosis and its role in disease.

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Apoptotic mechanisms in the pathophysiology of schizophrenia

11 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine

11 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

11 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Increased dopamine transmission in schizophrenia: relationship to illness phases

11 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

11 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

11 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia

11 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Antipsychotic drug effects on brain morphology in first-episode psychosis

11 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex

11 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Antipsychotic-induced oxidative stress in rat brain

11 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride

11 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex

11 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

11 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells

11 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia

11 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats

11 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

The natural history and pathophysiology of treatment resistant schizophrenia

11 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window

11 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol

11 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study

11 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study

11 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Differential changes in glutamatergic transmission via N-methyl-D-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine

11 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex

11 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia

11 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

Apoptosis in the nervous system

11 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.08.011

11 July 2024

Identifiers

1 reference

17 April 2018

1 reference

17 April 2018